Patient no. | Sex | Age (y) | Primary tumor | Imaged tumor site |
1 | M | 62 | NSCLC | Primary |
2 | M | 52 | NSCLC | Primary |
3 | M | 71 | Rectal adenocarcinoma | Metastasis to lung |
4 | F | 71 | NSCLC | Metastasis to adrenal gland |
5 | M | 74 | NSCLC | Metastasis to pelvic bone |
6 | F | 70 | NSCLC | Metastasis to pelvic bone |
7 | F | 62 | NSCLC | Metastasis to pelvic bone |
8 | F | 64 | Renal cell carcinoma | Local recurrence |
9 | M | 73 | Neuroendocrine carcinoma of lung | Metastasis to liver |
10 | M | 68 | Neuroendocrine carcinoma of lung | Lymph node metastasis |
11 | M | 68 | NSCLC | Primary |
12 | M | 80 | NSCLC | Primary |
13 | M | 58 | NSCLC | Primary |
Patients 12 and 13 were excluded because of movement or pulsation artifacts on MRI.